Lnk/Sh2b3 controls the production and function of dendritic cells and regulates the induction of IFN-γ-Producing T cells

Journal of Immunology

Volumn 193, Issue 4, 2014, Pages 1728-1736

  Mori, Taizo ^a   Iwasaki, Yukiko ^a,b   Seki, Yoichi ^a   Iseki, Masanori ^a   Katayama, Hiroko ^a   Yamamoto, Kazuhiko ^b   Takatsu, Kiyoshi ^c,d   Takaki, Satoshi ^a  

^a National Center for Global Health and Medicine   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

^d Toyama Prefectural Institute of Pharmaceutical Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 15; SH2B ADAPTOR PROTEIN 3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; INTERFERON INDUCTION; INTERFERON PRODUCTION; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN; T LYMPHOCYTE; TH1 CELL; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BONE MARROW CELLS; CELIAC DISEASE; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; GENOME-WIDE ASSOCIATION STUDY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-15; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOPOIESIS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-12; SPLEEN; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; THROMBOPOIESIS;

EID: 84905989323     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303243     Document Type: Article

References (47)

1. Kapsenberg, M. L. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3: 984-993.
2. Fogg, D. K., C. Sibon, C. Miled, S. Jung, P. Aucouturier, D. R. Littman, A. Cumano, and F. Geissmann. 2006. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311: 83-87.
3. Waskow, C., K. Liu, G. Darrasse-Jéze, P. Guermonprez, F. Ginhoux, M. Merad, T. Shengelia, K. Yao, and M. Nussenzweig. 2008. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 9: 676-683.
4. Onai, N., A. Obata-Onai, M. A. Schmid, T. Ohteki, D. Jarrossay, and M. G. Manz. 2007. Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat. Immunol. 8: 1207-1216.
5. Naik, S. H., P. Sathe, H.-Y. Park, D. Metcalf, A. I. Proietto, A. Dakic, S. Carotta, M. O'Keeffe, M. Bahlo, A. Papenfuss, et al. 2007. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat. Immunol. 8: 1217-1226.
6. Bogunovic, M., F. Ginhoux, J. Helft, L. Shang, D. Hashimoto, M. Greter, K. Liu, C. Jakubzick, M. A. Ingersoll, M. Leboeuf, et al. 2009. Origin of the lamina propria dendritic cell network. Immunity 31: 513-525.
7. Ginhoux, F., K. Liu, J. Helft, M. Bogunovic, M. Greter, D. Hashimoto, J. Price, N. Yin, J. Bromberg, S. A. Lira, et al. 2009. The origin and development of nonlymphoid tissue CD103+ DCs. J. Exp. Med. 206: 3115-3130.
8. Liu, K., G. D. Victora, T. A. Schwickert, P. Guermonprez, M. M. Meredith, K. Yao, F.-F. Chu, G. J. Randolph, A. Y. Rudensky, and M. Nussenzweig. 2009. In vivo analysis of dendritic cell development and homeostasis. Science 324: 392-397.
9. Varol, C., A. Vallon-Eberhard, E. Elinav, T. Aychek, Y. Shapira, H. Luche, H. J. Fehling, W.-D. Hardt, G. Shakhar, and S. Jung. 2009. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 31: 502-512.
10. Onai, N., K. Kurabayashi, M. Hosoi-Amaike, N. Toyama-Sorimachi, K. Matsushima, K. Inaba, and T. Ohteki. 2013. A clonogenic progenitor with prominent plasmacytoid dendritic cell developmental potential. Immunity 38: 943-957.
11. Huang, X., Y. Li, K. Tanaka, K. G. Moore, and J. I. Hayashi. 1995. Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C gamma 1, Grb2, and phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA 92: 11618-11622.
12. Takaki, S., J. D. Watts, K. A. Forbush, N. T. Nguyen, J. Hayashi, J. Alberola-Ila, R. Aebersold, and R. M. Perlmutter. 1997. Characterization of Lnk. An adaptor protein expressed in lymphocytes. J. Biol. Chem. 272: 14562-14570.
13. Takaki, S., K. Sauer, B. M. Iritani, S. Chien, Y. Ebihara, K. Tsuji, K. Takatsu, and R. M. Perlmutter. 2000. Control of B cell production by the adaptor protein lnk. Definition of a conserved family of signal-modulating proteins. Immunity 13: 599-609.
14. Takaki, S., H. Morita, Y. Tezuka, and K. Takatsu. 2002. Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk. J. Exp. Med. 195: 151-160.
15. Velazquez, L., A. M. Cheng, H. E. Fleming, C. Furlonger, S. Vesely, A. Bernstein, C. J. Paige, and T. Pawson. 2002. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J. Exp. Med. 195: 1599-1611.
16. Tong, W., and H. F. Lodish. 2004. Lnk inhibits Tpo-mpl signaling and Tpomediated megakaryocytopoiesis. J. Exp. Med. 200: 569-580.
17. Tong, W., J. Zhang, and H. F. Lodish. 2005. Lnk inhibits erythropoiesis and Epodependent JAK2 activation and downstream signaling pathways. Blood 105: 4604-4612.
18. Buza-Vidas, N., J. Antonchuk, H. Qian, R. Månsson, S. Luc, S. Zandi, K. Anderson, S. Takaki, J. M. Nygren, C. T. Jensen, and S. E. Jacobsen. 2006. Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK. Genes Dev. 20: 2018-2023.
19. Takizawa, H., K. Eto, A. Yoshikawa, H. Nakauchi, K. Takatsu, and S. Takaki. 2008. Growth and maturation of megakaryocytes is regulated by Lnk/Sh2b3 adaptor protein through crosstalk between cytokine-And integrin-mediated signals. Exp. Hematol. 36: 897-906.
20. Bersenev, A., C. Wu, J. Balcerek, and W. Tong. 2008. Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2. J. Clin. Invest. 118: 2832-2844.
21. Seita, J., H. Ema, J. Ooehara, S. Yamazaki, Y. Tadokoro, A. Yamasaki, K. Eto, S. Takaki, K. Takatsu, and H. Nakauchi. 2007. Lnk negatively regulates selfrenewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction. Proc. Natl. Acad. Sci. USA 104: 2349-2354.
22. Bersenev, A., C. Wu, J. Balcerek, J. Jing, M. Kundu, G. A. Blobel, K. R. Chikwava, and W. Tong. 2010. Lnk constrains myeloproliferative diseases in mice. J. Clin. Invest. 120: 2058-2069.
23. Oh, S. T., E. F. Simonds, C. Jones, M. B. Hale, Y. Goltsev, K. D. Gibbs, Jr., J. D. Merker, J. L. Zehnder, G. P. Nolan, and J. Gotlib. 2010. Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood 116: 988-992.
24. Pardanani, A., T. Lasho, C. Finke, S. T. Oh, J. Gotlib, and A. Tefferi. 2010. LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronicphase disease with TET2, IDH, JAK2 or MPL mutations. Leukemia 24: 1713-1718.
25. Vainchenker, W., F. Delhommeau, S. N. Constantinescu, and O. A. Bernard. 2011. New mutations and pathogenesis of myeloproliferative neoplasms. Blood 118: 1723-1735.
26. Takizawa, H., S. Nishimura, N. Takayama, A. Oda, H. Nishikii, Y. Morita, S. Kakinuma, S. Yamazaki, S. Okamura, N. Tamura, et al. 2010. Lnk regulates integrin aIIbb3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivo. J. Clin. Invest. 120: 179-190.
27. Todd, J. A., N. M. Walker, J. D. Cooper, D. J. Smyth, K. Downes, V. Plagnol, R. Bailey, S. Nejentsev, S. F. Field, F. Payne, et al. Genetics of Type 1 Diabetes in Finland; Wellcome Trust Case Control Consortium. 2007. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39: 857-864.
28. Hunt, K. A., A. Zhernakova, G. Turner, G. A. Heap, L. Franke, M. Bruinenberg, J. Romanos, L. C. Dinesen, A.W. Ryan, D. Panesar, et al. 2008. Newly identified genetic risk variants for celiac disease related to the immune response. Nat. Genet. 40: 395-402.
29. Smyth, D. J., V. Plagnol, N. M. Walker, J. D. Cooper, K. Downes, J. H. Yang, J. M. Howson, H. Stevens, R. McManus, C. Wijmenga, et al. 2008. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N. Engl. J. Med. 359: 2767-2777.
30. Coenen, M. J., G. Trynka, S. Heskamp, B. Franke, C. C. Van Diemen, J. Smolonska, M. Van Leeuwen, E. Brouwer, M. H. Boezen, D. S. Postma, et al. 2009. Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum. Mol. Genet. 18: 4195-4203.
31. Meresse, B., G. Malamut, and N. Cerf-Bensussan. 2012. Celiac disease: an immunological jigsaw. Immunity 36: 907-919.
32. Jabri, B., N. P. De Serre, C. Cellier, K. Evans, C. Gache, C. Carvalho, J. F. Mougenot, M. Allez, R. Jian, P. Desreumaux, et al. 2000. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 118: 867-879.
33. Yokota, A., H. Takeuchi, N. Maeda, Y. Ohoka, C. Kato, S. Y. Song, and M. Iwata. 2009. GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity. Int. Immunol. 21: 361-377.
34. Steinman, R. M., M. Pack, and K. Inaba. 1997. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156: 25-37.
35. Katayama, H., T. Mori, Y. Seki, M. Anraku, M. Iseki, M. Ikutani, Y. Iwasaki, N. Yoshida, K. Takatsu, and S. Takaki. 2014. Lnk prevents inflammatory CD8+ T-cell proliferation and contributes to intestinal homeostasis. Eur. J. Immunol. 44: 1622-1632.
36. Itoh, T., R. Liu, T. Yokota, K. I. Arai, and S. Watanabe. 1998. Definition of the role of tyrosine residues of the common b subunit regulating multiple signaling pathways of granulocyte-macrophage colony-stimulating factor receptor. Mol. Cell. Biol. 18: 742-752.
37. Kripke, M. L., C. G. Munn, A. Jeevan, J. M. Tang, and C. Bucana. 1990. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145: 2833-2838.
38. Henri, S., L. F. Poulin, S. Tamoutounour, L. Ardouin, M. Guilliams, B. De Bovis, E. Devilard, C. Viret, H. Azukizawa, A. Kissenpfennig, and B. Malissen. 2010. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J. Exp. Med. 207: 189-206.
39. Sathe, P., J. Pooley, D. Vremec, J. Mintern, J.-O. Jin, L. Wu, J.-Y. Kwak, J. A. Villadangos, and K. Shortman. 2011. The acquisition of antigen crosspresentation function by newly formed dendritic cells. J. Immunol. 186: 5184-5192.
40. Greter, M., J. Helft, A. Chow, D. Hashimoto, A. Mortha, J. Agudo-Cantero, M. Bogunovic, E. L. Gautier, J. Miller, M. Leboeuf, et al. 2012. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity 36: 1031-1046.
41. Ohteki, T., K. Suzue, C. Maki, T. Ota, and S. Koyasu. 2001. Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response. Nat. Immunol. 2: 1138-1143.
42. DePaolo, R. W., V. Abadie, F. Tang, H. Fehlner-Peach, J. A. Hall, W. Wang, E. V. Marietta, D. D. Kasarda, T. A. Waldmann, J. A. Murray, et al. 2011. Coadjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 471: 220-224.
43. Liu, K., C. Waskow, X. Liu, K. Yao, J. Hoh, and M. Nussenzweig. 2007. Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol. 8: 578-583.
44. Kingston, D., M. A. Schmid, N. Onai, A. Obata-Onai, D. Baumjohann, and M. G. Manz. 2009. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood 114: 835-843.
45. Naik, S. H., D. Metcalf, A. Van Nieuwenhuijze, I. Wicks, L. Wu, M. O'Keeffe, and K. Shortman. 2006. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 7: 663-671.
46. Codarri, L., G. Gyülvészi, V. Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter, and B. Becher. 2011. RORgt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12: 560-567.
47. El-Behi, M., B. Ciric, H. Dai, Y. Yan, M. Cullimore, F. Safavi, G.-X. Zhang, B. N. Dittel, and A. Rostami. 2011. The encephalitogenicity of TH17 cells is dependent on IL-1-And IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12: 568-575.